AAPP 2026 Schedule

Enjoy browsing through all that the AAPP 2026 Annual Meeting has to offer!

L1 = Level 1
L2 = Level 2
L3 = Level 3

LOOK CLOSELY at the time zone drop down! In-person attendees should have their time zone set to PDT (Pacific Daylight Time).

Customize your schedule by bookmarking sessions of interest using the bookmark () buttons. Then, filter the list below.

Sunday, April 19, 2026

-
The Pleasure Pain Balance in a Dopamine Overloaded World | Supported by the AAPP Foundation 1.00h ACPE
Anna Lembke, MD
Grand Ballroom (L2)
-
Real World/Practical Insights in New Medications 1.00h ACPE
Kevin Kavanagh, PharmD, BCPP, Aph; Hejab J. Khan, PharmD, BCPP; Hannah Wilkoff, PharmD, BCPP
Grand Ballroom (L2)
-
Beyond Childhood: Management of Autism Spectrum Disorder in Adults 1.00h ACPE
Gary Stobbe, MD
Grand Ballroom (L2)

Monday, April 20, 2026

-
Repurposing GLP-1 Receptor Agonists for Substance Use Disorders 1.00h ACPE
Stephanie Weiss, MD, PhD
Grand Ballroom (L2)
-
Beyond the Price Tag: Cost-Effectiveness of Today’s Psychotropic Medications 1.25h ACPE BCPP
Vera Reinstein, PharmD, BCPS, FNCAP
Grand Ballroom (L2)
-
Concurrent session
Overdose Prevention Centers: Research, Outcomes, and Clinical Relevance 1.00h ACPE
Brandon D.L. Marshall, PhD
GB A-D (L2)
-
Concurrent session
Navigating Early Psychosis: Strategies for Optimal Antipsychotic Treatment Selection 1.25h ACPE BCPP
Deepak K. Sarpal, MD
GB E-K (L2)
-
Concurrent session
Intended And Unintended Outcomes After FDA Pediatric Antidepressant Warnings 1.00h ACPE
Stephen Soumerai, ScD
GB A-D (L2)
-
Concurrent session
Never Let a Good Crisis Go to Waste: What Pharmacists Need to Understand about Helping People in Crisis 1.25h ACPE BCPP
Jack Rozel, MD, MSL, DFAPA
GB E-K (L2)
-
Concurrent session
Reshaping Perspectives: The Link Between Stigma and Health Inequities in Mental Health 1.00h ACPE
Carolanne Wartman, PharmD, BCPS, BCPP
GB A-D (L2)
-
Concurrent session
Deprescribing Psychotropics in Older Adults with Neuropsychiatric Disorders 1.25h ACPE BCPP
Nina Vadiei, PharmD, BCPP
GB E-K (L2)

Tuesday, April 21, 2026

-
Midlife Mood Management: A Pharmacy-Led Approach to Menopausal Mental Health 1.00h ACPE
Lisa Miller, PharmD, MSCP, LCMHCA, NCC
Grand Ballroom (L2)
-
Navigating Real Challenges: Applying Artificial Intelligence to Personalized Treatment Planning in Mental Health 1.25h ACPE BCPP
Andrea Sikora, PharmD, MSCR, FCCP, FCCM
Grand Ballroom (L2)
-
Concurrent session
Clinical Pearls 1.00h ACPE
Katie Bye, PharmD; Melanie Rovelo, PharmD, BCPP; Makenzie Harrison, PharmD, BCPP
GB A-D (L2)
-
Concurrent session
The Hidden Hangover: Managing Alcohol Use Disorder with Co-occurring Trauma 1.25h ACPE BCPP
Theresa Frey, PharmD, BCPP
GB E-K (L2)
-
Concurrent session
Stick with It: An Update on New Long-Acting Injectable Antipsychotics 1.00h ACPE
Andy Williams, PharmD, BCPP, FAAPP
GB A-D (L2)
-
Concurrent session
Medication Treatment of Social Anxiety Disorder: Beyond Serotonin Reuptake Inhibitors 1.25h ACPE BCPP
Franklin Schneier, MD
GB E-K (L2)
-
Concurrent session
Differences in Non-Suicidal Self-Injury (NSSI), Passive and Active Suicidal Ideation 1.00h ACPE
Ashley Perkins, PharmD, EdS, CPh
GB A-D (L2)
-
Concurrent session
The Mind-Body Connection: Integrating Psychiatric and Holistic Care in Fibromyalgia Management 1.25h ACPE BCPMP BCPP
Emily Leppien, PharmD, BCPS, BCPP
GB E-K (L2)

Wednesday, April 22, 2026

-
The Buprenorphine Bulletin: Navigating Updates to Prescribing 1.00h ACPE
Zachary Hill, PharmD, BCPP, MA
Grand Ballroom (L2)
-
Guideline Updates for the Psychiatric Pharmacist 1.00h ACPE
Lindsey Garner, PharmD, MBA, BCPS, BCPP
Grand Ballroom (L2)
-
Psychiatric and Neurologic Medication Pipeline 1.00h ACPE
Stephen R. Saklad, PharmD, BCPP, FAAPP
Grand Ballroom (L2)